Service interruption on Monday 11 July from 12:30 to 13:00: all the sites of the CCSD (HAL, EpiSciences, SciencesConf, AureHAL) will be inaccessible (network hardware connection).
Skip to Main content Skip to Navigation
Journal articles

Drug discovery: a research sector stricken in France that can sometimes pay off

Abstract : Drug discovery is a research sector stricken in France. Projects initiated by medicinal chemists from public sector could be a way to countervail this weakness.The present paper reports the case of a french drug design company, Trophos, founded by academic researchers, purchased by Roche Pharmaceuticals for 400 millionseuros in 2015. Following this success story,some Trophos founders have persevered in starting two new ‘’drug design companies’’.Since Trophos creation in year 2000, the costs to fulfill the preclinical phase have dramatically increased. It is why goverment research organizations should facilitate biotech creation by academic and public researchers, to make french drug discoverybusiness competitive again. Some ideas are suggested in this paper:a non-profit foundation which can de-risk investments and encourage innovation toward important unmet medical needs.
Document type :
Journal articles
Complete list of metadata

Cited literature [8 references]  Display  Hide  Download
Contributor : Sébastien Poulain Connect in order to contact the contributor
Submitted on : Friday, January 17, 2020 - 9:27:18 AM
Last modification on : Monday, January 17, 2022 - 1:23:28 PM
Long-term archiving on: : Saturday, April 18, 2020 - 12:21:13 PM


Drug Discov Today 2019 Jun10.1...
Files produced by the author(s)




Jean-Louis Kraus. Drug discovery: a research sector stricken in France that can sometimes pay off. Drug Discovery Today Biosilico, Elsevier, 2019, 24 (6), pp.1229-1231. ⟨10.1016/j.drudis.2019.05.002⟩. ⟨hal-02440814⟩



Record views


Files downloads